Summer Workshop: Overcome Patents – How to Replace an Undesired Molecular Scaffold

webinar

Wed, 07 Jul 2021, 16:00 CEST (Berlin)

Alexander Neumann, BioSolveIT

Summer Workshop: Overcome Patents – How to Replace an Undesired Molecular Scaffold

The workshop was postponed to July 7th due to some technical issues. New registrations are possible!

What to do if the most important part of a compound is the one limiting any progress? In its very true definition, the pharmacophore is one crucial part of the molecule that is responsible for its biological activity. But sometimes it is the part with the undesired properties: toxicity, promiscuity, unfavorable physicochemistry, or, even worse, so good that its patented.
In this BioSolveIT workshop we will tackle the topic of how to find good replacements for core structures with computational methods beyond those of conventional pharmacophore-based screenings. Detailed insights into medicinal chemistry will be accompanied by real-life applications and examples how to profit from accessible Chemical Spaces to reach your goal quickly and cost-efficiently.

Participants can request a certificate of attendance.

Current news

What's So Special About The 'Activity Spotter'? Detailed Insights Into SeeSAR's New Mode
April 29, 2026 10:22 CEST
SeeSAR’s Activity Spotter Mode is designed to dismantle the barrier of raw data and actionable SAR. It helps to answer the most relevant fields in hit-to-lead and lead optimization campaigns: 3D SAR and pharmacophore modeling. Which structural features in my molecule set are associated with activity? Which ones are linked...
Read on
Tool of the Month - FlexX
April 29, 2026 08:53 CEST
Spring is Molecular Docking Season The bread and butter of computational chemistry: predicting potential binding modes, which serves as a crucial foundation for SAR analysis and design decisions, is being made available to everyone this month with the proprietary docking tool FlexX. Validated by over 10,000 citations of its original...
Read on
The 95 Billion Update: Access the REAL Space
April 9, 2026 13:57 CEST
The latest update of Enamine’s REAL Space brings a new expansion, now featuring over 94.5 billion accessible, drug-like products, approaching the 100 billion mark. Built from 173 curated reaction protocols and 202,620 in-stock reagents and building blocks based on Enamine’s in-house knowledge, this version further enhances the world’s largest commercially...
Read on